Survival Rate of the Five Most Common Cancers in 2010 at Udonthani Cancer Hospital, Thailand
Keywords:Survival rate, Five most common cancers
AbstractObjective:To study the survival rate of the five most common cancers in 2010 at Udonthani Cancer Hospital, Thailand.Methods:The study design of this study was a retrospective cohort study. Survey the records all new cancer cases were diagnosedand treated at Udonthani cancer Hospital by the year 2010. All of cases were followed up the vital status until death or the end of study (December 31, 2016). The statistical analyzed included descriptive statistics, Kaplan-Meier survival Results. There were 1979 cases who were found 597 cases (30.1%) were still alive and 1,382 cases (69.8%) had died. The overall survival rates for 5 year was 32.3%. Analysis of five most common cancers as below. Result: Liver cancer most of them were male 69.8%, mean age 59.7 years (SD=10.8).The overall survival rate for 5 years was 3.9%. The 5-year stage-specific survivals had 100% for stage I, II, 5.6% for stage III and 3.4% for stage IV, respectively. Breast cancer most of them were female 99.4%, mean age 51.3 years (SD=10.5). The overall survival rate for 5 years was 66.3%. The 5-year stage-specific survivals had 90.70% for stage I, 75.44% for stage II, 61.7% for stage III and 26.0% for stage IV, respectively. Lung cancer most of them were male 67.4%, mean age 59.8 years (SD=10.7). The overall survival rate for 5 years was 8.2%. The 5-year stage-specific survivals had 15.3% for stage I, 100% for stage II, 14.8% for stage III and 5.8% for stage IV, respectively. Cervical Cancer all of them were female 100%, mean age 52.3 years (SD=11.8). The overall survival rate at 5 years was 50.9%. The 5-year stage-specific survivals had 67.5% for stage I, 72.6% for stage II, 27.7% for stage III and 20% for stage IV, respectively. Colorectal cancer most of them were male 52.6%, mean age 57.7 years (SD=12.8). The overall survival rate at 5 years was 32.3%. The 5-year stage-specific survivals had 80% for stage I, 63.6% for stage II, 39.6% for stage III and 10.1% for stage IV, respectively. Conclusions: The results indicated that the five most common cancers with stages of diagnosis had a lower survival rate. Additionally, the most prognosis factor was cellular/nuclear grading outcome were poor.
Strategy and Planning Division, Ministry of Public Health. Public Health Statistics A.D.2016. Mueang Nonthaburi: Health Information Unit, Strategy and Planning Division.
Ministry of public health. Cancer in Thailand Volume VIII 2010-2012. Bangkok : New Thammada Press (Thailand) Co., Ltd; 2015.
National Cancer Intitute.SEER Stat Fact Sheet; cancer 2007-2013. Available at:http://seer.cancer.gov/statfacts/ HTML. August 10, 2018.
Pensuwan P, Sodarat P, Chamnayeue Y, Saksaen P, Suebmueangsai O. Factors Effecting to Survival of Intrahepatic Cholangiocarcinoma after Surgical Treatment among Admitted Patients in Roi Et Hospital. Journal of Health Science 2016; 25:137-145.
Wirasorn K, Rattananukrom C, Pituso S, Luvira V, Punjaruk W. Hepatocellular Carcinoma in Srinagarind Hospital: A FiveYear Period of Hospital Records. Srinagarind Med J2015; 30:122-128.
Soimadee S. Overall Survival and Prognostic Factors for Breast Cancer Patients at Vachira Phuket Hospital. Thai cancer Journal 2017; 37:62-71.
Ongart S, Somsuda S, Krittika S. Breast Cancer in Srinagarind Hospital (2000-2010), Khon Kaen, Thailand. Srinagarind Medical Journal 2015; 30:87-98.
Gakwaya A, Kigula-Mugambe JB, Kavuma A, Luwaga A, Fualal J, Jombwe J, et al. Cancer of the breast: 5-year survival in a tertiary hospital in Uganda. Br J Cancer 2008; 99:63-7.
Somintara O, Somintara S, Suwanrungruang K. Breast cancer in Srinagarind Hospital(2000-2010), Srinagarind Med J 2015; 30:87-93.
Punjaruk W, Suwanrungruag K, Wirasorn K. Non-small Cell Lung Cancer (NSCLC) in Srinagarind Hospital: 2000-2010, Hospital Based. Srinagarind Med J 2015; 30:110-115.
Wang BY, Huang JY, Cheng CY, Lin CH, Ko J, Liaw YP. Lung cancer and prognosis in Taiwan: a population – based cancer registry. J Thorac Oncol 2013; 8:1128-35.
Riihimki M, Hemminki A, Fallah M, Thomsen H, Sundquist K, Sundquist J, et al. Metastatic sites and survival in lung cancer. Lung Cancer Amst Neth 2014; 86: 78-84.
Pengsaa P, Pesi M, Udomthavornsuk B, Tungvorapongchai V, Vatanasapt W, Shibata Y. Survivalanalysisofcervical cancer patients at Srinagarind Hospital1976-1987. J Med Assoc Thai 1989; 72:346-50.
Farid Aziz M, Gynecologicalcancerin Indonesia. J Gynecoloncol 2009; 20:8–10.
Kostova P, Zlatkov V, Danon S. Five-year overall survival and prognostic factors in patients with cervical cancer in Bulgaria. J BUON 2008; 13:363-8.
Sirikit W, Promrattanapong P, Kanittachart C, Sangrueng-Orn S.The Five-year Overall Survival Rate of Cervical Cancer Patients Who were Treated by Irridium-192 High Dose Rate (HDR) Brachytherapy at Tadio therapy Department, Phramongkutklo Hospital. RTA Med J 2012; 65:231-8.
Sanersak Swangvaree S, Tangprasert N, Adulbhan A, Foongfaung S. Talacheep S, Muangsamran O, et al. Cervical cancer survival at the national cancer institute, Thailand. Thai cancer J 2010; 30:87-93.
Laohavinij S, Maneechavakajorn J, Techatanol P. Prognostic factors for survival in colorectal cancer patients. J Med AssocThail Chotmaihet Thangphaet 2010; 93: 1156–66.
Pongtanoo P. Servival Rate of colorectal cancer Patients in Khon Kaen Province. Journal of Sakon Nakhon Hospital 2016; 2:243-251.
Heidarnia MA, Monfared ED, Akbari ME, Yavari P, Amanpour F, Mohseni M, et al. Social determinants of health and 5-year survival of colorectal cancer. Asian Pac J Cancer Prev 2013; 14:5111-6.
How to Cite
ข้อความและข้อคิดเห็นต่างๆ เป็นของผู้เขียนบทความ ไม่ใช่ความเห็นของกองบรรณาธิการหรือของวารสารกรมการแพทย์